Combined Effects of 5-Azacytidine and Oleuropein on miR-149-3p, miR-375, miR-574-5p Expression and Apoptosis in HL-60 and THP-1 Cell Lines
Preprint
- 17 July 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Acute myeloid leukemia (AML) is an aggressive hematological malignancy characterized by the rapid expansion of immature myeloid cells and poor clinical outcomes. Despite conventional treatments, including chemotherapy and hematopoietic stem cell transplantation, relapse and resistance remain significant challenges. Epigenetic alterations, particularly dysregulated DNA methylation and microRNA (miRNA) expression, play a crucial role in AML pathogenesis. Objective This study aimed to evaluate the synergistic effects of azacitidine, a DNA methyltransferase inhibitor, and oleuropein, a natural polyphenol with anticancer properties, on AML cell lines (THP-1 and HL-60). Methods AML cells were treated with azacitidine, oleuropein, and their combination. Cell proliferation was assessed using MTT assays, apoptosis was analyzed via flow cytometry (Annexin V-FITC/PI staining), and miRNA expression levels were quantified using real-time PCR. Results Both azacitidine and oleuropein reduced cell viability and induced apoptosis in a dose- and time-dependent manner. Notably, the combination treatment significantly enhanced apoptosis, with a 2.5-fold increase in Annexin V-positive HL-60 cells at 72 hours. Furthermore, the treatment modulated miRNA expression, upregulating miR-149-3p and miR-375 while downregulating miR-574-5p. Conclusion The synergistic effects of oleuropein and azacitidine suggest a potential therapeutic strategy for AML by targeting epigenetic mechanisms and miRNA pathways. Further in vivo studies and clinical trials are necessary to validate these findings and optimize treatment protocols.Keywords
All Related Versions
- Version 1, 2025-07-17, Research Square
- Published version: Molecular Biology Reports, 52 (1), 1.
This publication has 12 references indexed in Scilit:
- Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutationsHematology, 2024
- Oleuropein as An Effective Suppressor of Inflammation and MicroRNA-146a Expression in Patients with Rheumatoid Arthritis2023
- A Comprehensive Review on the Anti-Cancer Effects of OleuropeinLife, 2022
- Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)International Journal of Oncology, 2021
- miR-149-3p suppressed epithelial–mesenchymal transition and tumor development in acute myeloid leukemiaHematology, 2021
- miR-574-5p Targets FOXN3 to Regulate the Invasion of Nasopharyngeal Carcinoma Cells via Wnt/β-Catenin PathwayTechnology in Cancer Research & Treatment, 2020
- miR-149-3p reverses CD8 + T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cellsOpen Biology, 2019
- A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemiaBMC Cancer, 2018
- MicroRNA-574-5p promotes metastasis of non-small cell lung cancer by targeting PTPRUScientific Reports, 2016
- Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell lineMolecular Medicine Reports, 2015